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Abstract
Background: Recent life expectancy gains in high-income Asia-pacific countries have been largely the result of
postponement of death from non-communicable diseases in old age, causing rapid demographic ageing. This
study compared and quantified age- and cause-specific contributions to changes in old-age life expectancy in two
high-income Asia-pacific countries with ageing populations, South Korea and Japan.
Methods: This study used Pollard’s actuarial method of decomposing life expectancy to compare age- and cause-
specific contributions to changes in old-age life expectancy between South Korea and Japan during 1997 and 2017.
Results: South Korea experienced rapid population ageing, and the gaps in life expectancy at 60 years old between
South Korea and Japan were reduced by 2.47 years during 1997 and 2017. Decomposition analysis showed that
mortality reductions from non-communicable diseases in South Korea were the leading causes of death
contributing to the decreased gaps in old-age life expectancy between the two countries. More specifically,
mortality reductions from cardiovascular diseases (stroke, ischaemic and hypertensive heart disease) and cancers
(stomach, liver, lung, pancreatic cancers) in South Korea contributed to the decreased gap by 1.34 and 0.41 years,
respectively. However, increased mortality from Alzheimer and dementia, lower respiratory tract disease, self-harm
and falls in South Korea widened the gaps by 0.41 years.
Conclusions: Age- and cause- specific contributions to changes in old-age life expectancy can differ between high-
income Asia-pacific countries. Although the gaps in old-age life expectancy between high-income Asia-pacific
countries are primarily attributed to mortality changes in non-communicable diseases, these countries should also
identify potential emerging threats of communicable diseases and injuries along with demographic ageing in
pursuit of healthy life years in old age.
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Background
Recent life expectancy gains in high-income Asia-pacific
countries, as classified by the IMF, including Australia,
New Zealand, Japan, Hong Kong SAR, Republic of
Korea, Taiwan Province of China and Singapore, are
largely the result of enhanced longevity at older ages,
and this trend leads to rapid population ageing in those
countries [1, 2]. Although the factors which explain life
expectancy gains are multifaceted, previous studies have
demonstrated that this has largely resulted from im-
provements in effectiveness and coverage of healthcare
[3]. From a theoretical perspective, the ‘epidemiological
transition theory’ relates changing patterns of population
distributions to leading causes of death from one pre-
dominant group of infectious diseases in developing na-
tions to what Abdel Omran referred to ‘degenerative
and man-made diseases’ in developed nations [4].
Recent comparative studies of life expectancy and
causes of death between high-income Asia-pacific
countries showed that causes of death contributing to
the changes in life expectancy can differ between
them [5–7]. These studies, however, have tended to
focus on changes in life expectancy within countries,
while gaps in life expectancy between countries have
received less attention. Exploring the gaps in life ex-
pectancy between countries can enhance understand-
ing of causes of the gaps in life expectancy and
facilitate cross-national policy learning. A combined
analysis of changes in life-expectancy within and gaps
in life expectancy between high-income Asia-pacific
countries is the first novelty of this study. The second
novelty is that this study uses an elderly population-
focused approach for a comparative study of cause of
death and life expectancy. Previous studies have sub-
stantially concentrated on life expectancy at birth, but
this approach may not necessarily correspond to life
expectancy at an older age, or may overlook different
mortality trajectories among the elderly population in
high-income Asia-pacific countries. Therefore, this
study provides new insights into the gaps in old-age
life expectancy between high-income Asia-pacific
countries in an era of global population ageing.
Among high-income Asia-pacific countries, the Re-
public of Korea (hereafter South Korea) and Japan have
both experienced demographic ageing due to rapidly in-
creasing longevity and declining fertility rates. As a re-
sult, Japan has been widely regarded as the most aged
country in the world and South Korea, with the fastest
ageing population in the world, is projected to take the
lead in life expectancy from Japan between 2030 and
2040 [8]. Although South Korea and Japan share many
features in terms of demographic changes, health policy
directions and geography [8–15], there has been limited
evidence from comparative studies of age- and cause-
specific contribution to life expectancy among the eld-
erly in the two countries. It is therefore of interest to
closely compare age- and cause-specific contributions to
the recent changes in life expectancy among the elderly
between South Korea, the potential life expectancy
leader, and Japan, currently first in life expectancy.
Age 65 is usually used as an old age threshold, because
in some countries it is the age at which people could be
eligible for a full state pension. However, in South Korea,
normal pension age is now in the process of change. As
of 2020, individuals over 62 years old were eligible for
the normal pension in South Korea, and the criterion
was 60 years old until 2012. In Japan, the old age basic
pension benefits are currently paid from 65 years old,
whereas the pension age was 60 years old in the 1990s.
Since this study compares old-age life expectancy be-
tween the two countries in 1997 and 2017, this study de-
fines older adults as aged 60 years or older. The aim of
this study is therefore to report on a comprehensive
comparative study of age- and cause-specific contribu-
tions to changes in life expectancy at 60 years between
South Korea and Japan. This study focuses on popula-
tion data between 1997 and 2017 and observes (1) age
structural changes; (2) age-standardised mortality rates;
and explores (3) age- and cause-specific contributions to
increasing life expectancy at 60 years in South Korea and
Japan and (4) age- and cause-specific contributions to
decreasing gaps in life expectancy at 60 years between
South Korea and Japan.
Methods
Data
This study obtained data of the South Korean and Japa-
nese population by five-year age groups from the World
Population Prospects (WPP) 2019, and age- and cause-
specific deaths from the Global Burden of Disease
(GBD) 2017 Study [16]. The World Population Prospects
and GBD data are publicly available on websites of the
World Population Prospects (https://population.un.org/
wpp/) and the Global Health Data Exchange (http://
ghdx.healthdata.org). The GBD 2017 study follows the
Guidelines for Accurate and Transparent Health Esti-
mates Reporting (GATHER), which includes recommen-
dations on documentation of data sources, estimation
methods, and statistical analysis. Detailed methods for
the GBD 2017 study are provided in other publications
[17]. The GBD 2017 study organises causes of death in a
hierarchical list containing four levels. At the highest
level (Level 1), all disease burdens are divided as three
mutually exclusive and collectively exhaustive categories:
communicable, maternal, neonatal, and nutritional
(CMNN) diseases; non-communicable diseases (NCDs);
and injuries. Level 2 distinguishes the Level 1 category
into 21 cause groups, and Level 3 disaggregates these
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causes further, into 169 cause groups. The GBD data is
available in the form of the number of deaths in point
estimates and 95% uncertainty intervals. This study par-
ticularly used the mean values of the number of specific
causes of death at Level 3 for both sexes in South Korea
and Japan between 1997 and 2017. Among 169 causes of
death, the top 20 causes of death for persons ages 60
years and older based on South Korea in 2017 were fil-
tered out, and the remaining causes were merged into
the ‘Others’ category. Figure 1 shows the top 20 causes
of death in South Korea and Japan in 1997 and 2017. Al-
though the ‘Others’ category slightly increased from
1997 to 2017 in both countries, the top 20 causes
accounted for almost 80% of the total number of deaths
in both countries for the two periods. In addition, the
top 20 causes based on South Korea in 2017 were se-
lected to explore the causes of death among the elderly
in contemporary developed societies and investigate how
South Korea caught up with the old-age life expectancy
of Japan between 1997 and 2017.
Analysis
A descriptive analysis of age structural changes in South
Korea and Japan between 1997 to 2040 was carried out
with the WPP 2019 data. Then, the multiple decrement
table by five-year age groups for both countries between
1997 and 2017 was constructed to compute life expect-
ancy (LE). A broad mathematical assumption of the
multiple decrement life table is that an individual surviv-
ing to a certain age is the product of all independent
risk-of-death probabilities. Although sampling variation
is not an essential issue when calculating LE at national
levels, we used Monte Carlo simulations using the prob-
ability of dying from an abridged life table to generate a
binomial distribution of death numbers. The simulation
was performed 10,000 times to generate the LE distribu-
tion, where the mean value was used as LE and the 2.5th
and 97.5th percentiles of the distribution were used as
the 95% confidence interval of LE. Calculation tech-
niques for multiple decrement life tables and the stand-
ard error of LE are described elsewhere [18, 19].
In order to compare cause-specific mortality rates, this
study uses age-standardised mortality rates per 1000 per-
sons, with a direct method of standardisation further cal-
culated to eliminate the effect of different age structures
among the different population structures across two
countries and times. The directly standardised mortality
rate is given by the following formula;







where dit is the number of deaths for each specific cause
of mortality t at age i; pi denotes the number of persons
at age i in the observed population; Nr is the total num-
ber of persons in the reference population; pir denotes
the number of persons at age i in the reference popula-
tion. The population to be used as a reference was de-
rived from the average of the age distributions of South
Korean and Japan in 1997 and 2017 at each age group.
In addition, the Chi-square test was calculated for
Fig. 1 Proportion of top twenty causes of death for persons aged 60 years and older at IHME’s Level 3 category in South Korea and Japan
between 1997 and 2017
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testing the significance of differences in age-standardised
mortality rates (ASMR) of the two countries between
1997 and 2017.
Pollard’s actuarial method of decomposing life expect-
ancy was then used to estimate the age- and cause-
specific contributions to changes in life expectancy [20,
21]. This method was selected because it allows for sim-
ultaneously decomposing both different age groups and
different causes of death. The decomposition method
was calculated to examine the difference in life expect-
ancy of (1) South Korea between 1997 and 2017 and (2)















ðxP201760 e1997x þ xP199760 e2017x Þ:
where e2017x and e
1997
x are the life expectancies at age x
in 2017 and 1997 for the the decomposition of life ex-
pectancy within countries; n denotes the number of
causes of death; iQ2017x and iQ
1997
x is the mortality rate of
the i cause of death at age interval x with the weight ωx.
The values xP201760 and xP
1997
60 denote the probability of
surviving from 60 years old to 60 + x years of age be-
tween different times.
The same decomposition method was further calcu-
lated to examine the difference in life expectancy be-
tween (3) South Korea and Japan in 1997, and (4) South















ðxP j60ekx þ xPk60e jxÞ:
where j corresponding to Japan and k corresponding
to South Korea for the decomposition of life expectancy
between countries with the weight ωx between different
countries. This study based all life expectancy estimates
on the population aged 60-64.
Results
Rapid population ageing and fertility declined in South
Korea
Figure 2 depicts the UN medium variant projection esti-
mates of age structural changes in South Korean and
Japan [1]. The proportion of elderly population over 60
years of age increased in both countries from 1997 to
2017 and is projected to further grow in 2040, as shown
in the population pyramids in Fig. 2a (top grey bars). Al-
though Japan had larger proportions of the population
over 60 years of age in 1997 and 2017, the proportion in
Fig. 2 Population pyramids a and proportions of old and young age groups b of South Koreans and Japanese between 1997 and 2040
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2040 is expected to be more or less equal between the
two countries, 40% in South Korea and 42% in Japan. In
terms of the pace of population ageing, while Japan
seems to follow a gradually increasing trend in propor-
tions of the population over 60 years old, South Korea
seems to follow a steadily increasing trend between 1997
and 2040 (see Fig. 2b). Particularly, the projected in-
crease from 2017 to 2040 in the proportions of the
population over 60 years old in South Korea is striking,
as South Korea is expected to catch up with Japan’s four
decades of growth just in the next two decades. Further-
more, the proportions of the population under 15 years
old (bottom grey bars in Fig. 2 a) in South Korea shrank
between 1997 and 2017 at a much faster pace than in
Japan. Hence, in comparison with Japan, South Korea
experienced faster population ageing, accompanied by
precipitous falls in birth rates; and hence the country is
very likely to face much more pressing demographic
challenges in the next 20 years.
Changes in life expectancy and age-standardised
mortality rates in older people
Although both countries experienced increases in old-age
life expectancy between 1997 and 2017, South Korea rap-
idly caught up with life expectancy in Japan(see Table 1).
Life expectancy at age 60 was 20.09(±0.04) years for South
Korea and 23.87(±0.02) years for Japan in 1997, whereas
the gap narrowed in 2017, as life expectancy increased to
25.09(±0.03) years for South Korea and 26.40(±0.01) years
for Japan. The gaps in old-age life expectancy between the
two countries therefore decreased by 2.47 from 3.78 in
1997 to 1.31 in 2017.
Table 2 shows estimated age-standardised mortality
rates (ASMRs) per 1000 persons for the population aged
60 years and older in South Korea and Japan between
1997 and 2017. Between 1997 and 2017, age-
standardised all-cause mortality rates decreased from
47.9 to 27.4 in South Korea and from 31.2 to 23.4 in
Japan. The comparative mortality figure (CMF) in Table
2 is defined as the expected number of deaths in the
standard population compared with those observed [22].
The CMF shows that in 1997 all-cause mortality of the
elderly population in South Korea was 54% higher than
in Japan, but the figure decreased to 17% in 2017. The
last column shows the changes in ASMRs of each cause
from 1997 to 2017, where negative figures indicate falls
and positive signs indicate rises in ASMRs over the pe-
riods. ASMRs from stroke and ischemic heart disease
largely declined in both countries. The highest ASMRs
at old ages in 1997 were observed in stroke in both
countries, but they were Alzheimer’s disease and demen-
tia for both countries in 2017. On the other hand,
ASMRs rose from a few causes between 1997 and 2017.
While only one cause in Japan 2017, pancreatic cancer,
had higher ASMRs than those in 1997, South Korea ex-
perienced increased ASMRs from four causes: Parkin-
son’s disease, lower respiratory tract disease, self-harm
and falls. Interestingly, the increased figure in Japan was
only categorised in non-communicable disease within
the IHME’s Level 1 category; however, the increased fig-
ures of the four causes in South Korea were categorised
within all the three Level 1 classifications, Communic-
able, Non-Communicable disease and Injuries. More-
over, ASMRs of lower respiratory tract disease in Japan
were higher than South Korea in both years, but the two
countries had opposite trends, from 2.6 to 1.9 in Japan,
from 0.9 to 1.5 in South Korea. The Chi-square test
showed that difference in ASMRs between 1997 and
2017 was statistically significant in South Korea, which
was primarily derived from mortality declines in non-
communicable disease.
Age- and cause-specific contributions to increasing old
age life expectancy within countries
Life expectancy at 60 years increased by 5 years in South
Korea and 2.53 years in Japan between 1997 and 2017.
Table 1 Life expectancy at 60 years and older of South Korea and Japan in 1997 and 2017
Age
group





Korea (a) Japan (b) Korea (c) Japan (d) 1997 (b-a) 2017 (d-c)
LE 60 20.09 ± 0.04 23.87 ± 0.02 25.09 ± 0.03 26.40 ± 0.01 3.78 1.31 −2.47
LE 65 16.29 ± 0.04 19.77 ± 0.02 20.74 ± 0.03 22.15 ± 0.01 3.48 1.41 −2.07
LE 70 12.74 ± 0.04 15.93 ± 0.02 16.60 ± 0.03 18.04 ± 0.02 3.19 1.44 −1.75
LE 75 9.66 ± 0.04 12.35 ± 0.02 12.82 ± 0.02 14.18 ± 0.01 2.69 1.36 −1.33
LE 80 7.11 ± 0.04 9.19 ± 0.02 9.48 ± 0.03 10.67 ± 0.01 2.08 1.19 −0.89
LE 85 5.10 ± 0.04 6.61 ± 0.02 6.75 ± 0.03 7.69 ± 0.02 1.51 0.94 −0.57
LE 90 3.57 ± 0.06 4.63 ± 0.02 4.71 ± 0.04 5.30 ± 0.02 1.06 0.59 −0.47
LE 95 2.61 ± 1.00 3.14 ± 0.04 3.31 ± 0.06 3.45 ± 0.02 0.53 0.14 −0.67
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Table 3, columns 1 and 2 show the age-specific contri-
butions to the changes in old age life expectancy in
South Korea and Japan between 1997 and 2017. The
contributions to the 5 year life expectancy gains in South
Korea were from across all old age groups, but the lar-
gest contribution was observed in the 70–79 age group
in South Korea. Life expectancy gains for Japanese old
adults also occurred across all old age groups, but the
largest improvement was observed in the 75–84 age
group. Table 4, columns 1 and 2 show the cause-specific
contribution to the change in life expectancy in South
Korea and Japan between 1997 and 2017. Reduced mor-
tality from stroke and ischaemic heart disease explained
most of the increase in life expectancy and mortality re-
ductions from cancers also explained a large part of the
increase in both countries. In relation to the ASMRs,
increased mortality from lower respiratory tract disease,
self-harm and falls slightly led to decreasing life-
expectancy of South Korean old adults between 1997
and 2017. In addition, the increased mortality from Par-
kinson’s disease and pancreatic cancer in South Korea
and Japan, respectively, between 1997 and 2017 led to
the marginal decreases in life expectancy of South Ko-
rean and Japanese old adults. Figure 3 depicts age- and
cause-specific contributions of aggregate figures of 20
causes within the Level 1 category to the changes in life
expectancy of Korean and Japanese old adults between
1997 and 2017. It shows that large improvements were
found in the 70–79 age groups in South Korea while im-
provements were pronounced in the 75–84 age groups
in Japan. The figure also clearly illustrates that, among
20 causes, reduced mortality from non-communicable
Table 2 Age- standardised mortality rates for 20 causes of death among older adults in South Korea and Japan between 1997 and
2017
Cause of Death ASMR per 1000 (95% CI) Differences between 1997 and
2017
1997 2017 Korea Japan
Korea Japan Korea Japan
Non-communicable disease 35.2 (32.3–38.4) 21.8 (21.4–22.4) 19.2 (16.8–22.2) 15.6 (14.8–16.5) −15.9* −6.2
Stroke 10.4(9.7–11.0) 4.6(4.5–4.6) 3.1(2.8–3.5) 2.4(2.3–2.5) −7.2 −2.2
Ischaemic heart disease 5.5(5.0–6.0) 4.3(4.3–4.4) 2.6(2.3–3.0) 2.6(2.5–2.7) − 2.8 −1.8
Stomach cancer 2.6(2.4–2.8) 1.6(1.6–1.6) 0.9(0.8–1.1) 1.0(1.0–1.1) −1.7 −0.6
Cirrhosis / liver diseases 1.6(1.4–1.8) 0.5(0.5–0.5) 0.5(0.4–0.6) 0.4(0.4–0.5) −1.1 −0.1
Chronic obstructive pulmonary disease 1.8(1.6–2.1) 0.9(0.8–0.9) 1.1(1.1–1.3) 0.6(0.6–0.7) −0.7 −0.3
Liver cancer 1.5(1.3–1.6) 1.0(1.0–1.0) 0.9(0.8–1.1) 0.6(0.5–0.7) − 0.6 − 0.4
Tracheal / lung cancer 2.2(2.0–2.4) 1.6(1.6–1.7) 1.7(1.5–1.9) 1.5(1.4–1.5) − 0.5 − 0.1
Diabetes mellitus 1.6(1.5–1.8) 0.2(0.2–0.2) 1.1(0.9–1.3) 0.1(0.1–0.1) − 0.5 − 0.1
Alzheimer / dementia 4.3(4.1–4.5) 3.4(3.3–3.4) 4.0(3.7–4.4) 3.3(3.1–3.4) − 0.3 − 0.1
Gallbladder cancer 0.6(0.5–0.7) 0.5(0.5–0.5) 0.4(0.4–0.5) 0.4(0.4–0.4) − 0.2 − 0.1
Hypertensive-heart disease 0.8(0.6–1.1) 0.3(0.3–0.5) 0.5(0.4–0.8) 0.2(0.2–0.4) − 0.2 − 0.1
Chronic kidney disease 0.7(0.6–0.8) 0.9(0.9–0.9) 0.6(0.5–0.7) 0.6(0.6–0.7) − 0.1 − 0.3
Pancreatic cancer 0.5(0.5–0.6) 0.6(0.6–0.6) 0.5(0.4–0.8) 0.6(0.6–0.7) − 0.1 0.1
Colon and rectal cancer 0.8(0.8–0.9) 1.1(1.1–1.1) 0.8(0.7–1.0) 1.0(1.0–1.1) 0 −0.1
Parkinson’s disease 0.3(0.3–0.4) 0.3(0.2–0.3) 0.3(0.2–0.4) 0.3(0.2–0.3) 0.1 0.0
Communicable disease 1.9(1.6–2.1) 2.8(2.7–2.9) 1.7(1.5–2.1) 1.9(1.8–2.0) − 0.1 − 0.9
Tuberculosis 0.9(0.8–1.1) 0.2(0.2–0.2) 0.3(0.2–0.3) 0.1(0.1–0.1) − 0.7 − 0.1
Lower respiratory tract 0.9(0.8–1.0) 2.6(2.5–2.7) 1.5(1.3–1.7) 1.9(1.8–2.0) 0.6 − 0.7
Injuries 1.5(1.4–1.7) 0.8(0.8–0.8) 1.3(1.1–1.6) 0.6(0.6–0.6) −0.1 − 0.2
Road injuries 0.8(0.8–0.9) 0.2(0.2–0.2) 0.4(0.3–0.4) 0.1(0.1–0.1) − 0.4 − 0.1
Falls 0.3(0.3–0.4) 0.2(0.2–0.2) 0.3(0.3–0.4) 0.2(0.2–0.2) 0.1 −0.1
Self-harm 0.4(0.3–0.4) 0.4(0.4–0.4) 0.6(0.5–.0.7) 0.3(0.3–0.3) 0.3 −0.1
others 9.3(7.5–11.3) 5.7(5.2–6.3) 5.0(3.8–6.2) 5.2(4.5–5.9) −4.3 − 0.5
Total 47.9 (42.9–53.5) 31.2 (30.0–32.4) 27.4 (23.3–32.0) 23.4. (21.7–25.1) −20.4* −7.8
CMF 1.54 1.00 1.17 1.00
Note: * significant at 10% level
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Table 3 Age specific contributions to the changes in life expectancy in South Korea and Japan
Age Gap in Korea LE
Between 1997 and 2017
Gap in Japan LE
Between 1997 and 2017
Gap in LE between Korea
and Japan in 1997 (a)
Gap in LE between Korea
and Japan in 2017 (b)
Changes in gaps between
2017 and 1997 (b-a)
Years % Years % Years % Years % Years %
60–64 0.74 14.8 0.27 10.7 0.47 12.4 −0.02 −1.5 − 0.49 19.8
65–69 0.83 16.6 0.37 14.6 0.52 13.7 0.04 3.0 −0.48 19.4
70–74 0.96 19.2 0.39 15.4 0.74 19.5 0.16 12.1 −0.58 23.5
75–79 0.96 19.2 0.45 17.8 0.79 20.8 0.28 21.2 −0.51 20.6
80–84 0.79 15.8 0.47 18.6 0.64 16.9 0.33 25.0 −0.31 12.6
85–89 0.47 9.4 0.36 14.2 0.40 10.6 0.31 23.5 −0.09 3.6
90–94 0.20 4.0 0.18 7.1 0.20 5.3 0.23 17.4 + 0.03 −1.2
95+ 0.05 1.0 0.04 1.6 0.03 0.8 −0.01 −0.70 −0.04 1.7
Total 5.00 100 2.53 100 3.79 100 1.32 100 −2.47 100
Table 4 Cause-specific contributions to the changes in life expectancy in South Korea and Japan
Cause of Death Gap in Korea LE
Between 1997 and
2017
Gap in Japan LE
Between 1997 and
2017
Gap in LE between
Korea and Japan in
1997 (a)
Gap in LE between





years % years % years % years % years %
Non-communicable disease 3.97 79.4 2.02 79.8 3.11 82.1 1.16 87.9 −1.95 78.9
Stroke 1.72 34.4 0.66 26.1 1.36 35.9 0.26 19.7 −1.1 44.5
Stomach cancer 0.45 9.0 0.21 8.3 0.26 6.9 −0.02 −1.5 −0.28 11.3
Ischaemic heart disease 0.65 13.0 0.54 21.3 0.24 6.3 0.01 0.8 −0.23 9.3
Cirrhosis / liver diseases 0.27 5.4 0.03 1.2 0.26 6.9 0.03 2.3 −0.23 9.3
Tracheal / lung cancer 0.16 3.2 0.06 2.4 0.16 4.2 0.08 6.1 −0.08 3.2
Pancreatic cancer 0.01 0.2 −0.02 −0.8 − 0.01 −0.3 − 0.05 −3.8 −0.04 1.6
Diabetes mellitus 0.18 3.6 0.03 1.2 0.36 9.5 0.32 24.2 −0.04 1.6
Chronic obstructive pulmonary disease 0.16 3.2 0.08 3.0 0.18 4.7 0.14 10.6 −0.04 1.6
Liver cancer 0.16 3.2 0.15 5.9 0.12 3.2 0.11 8.3 −0.01 0.4
Hypertensive-heart disease 0.07 1.4 0.04 1.6 0.09 2.4 0.08 6.1 −0.01 0.4
Colon / rectal cancer 0.01 0.2 0.04 1.6 −0.07 −1.8 − 0.07 −5.3 −0.00 0.1
Gallbladder cancer 0.05 1.0 0.05 2.0 0.02 0.5 0.02 1.5 −0.00 0.1
Parkinson’s disease −0.01 − 0.2 0.00 0.0 0.01 0.3 0.01 0.8 −0.00 0.0
Chronic kidney disease 0.03 0.6 0.09 3.6 −0.02 −0.5 0.00 0.0 + 0.02 −0.8
Alzheimer / dementias 0.06 1.2 0.06 2.4 0.15 4.0 0.24 18.2 + 0.09 −3.6
Communicable disease 0.07 1.4 0.26 10.3 −0.13 −3.4 −0.04 − 3.0 + 0.09 − 3.6
Tuberculosis 0.16 3.2 0.04 1.6 0.17 4.5 0.07 5.3 −0.1 4.1
Lower respiratory tract −0.09 −1.8 0.22 8.7 −0.3 −7.9 −0.11 −8.3 + 0.19 −7.7
Injuries 0.07 1.4 0.07 2.8 0.18 4.7 0.25 18.9 + 0.07 −2.8
Road injuries 0.15 3.0 0.04 1.6 0.16 4.2 0.1 7.6 −0.06 2.4
Falls −0.01 −0.2 0.01 0.4 0.02 0.5 0.04 2.9 + 0.02 −0.8
Self-harm −0.07 −1.4 0.02 0.8 0.00 0.0 0.11 8.3 + 0.11 −4.5
Others 0.89 17.8 0.18 7.1 0.63 16.5 −0.05 −3.8 −0.68 27.5
Total 5.00 100 2.53 100 3.79 100 1.32 90.9 −2.47 100
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disease greatly contributed to the increases in life ex-
pectancy at 60 years in both countries between 1997 and
2017; however, the contribution of communicable dis-
eases to the increases was larger in Japan.
Age- and cause-specific contributions to decreasing gaps
in old age life expectancy between countries
Between 1997 and 2017, life expectancy gaps at 60 years
of age between South Korea and Japan decreased by 2.47
from 3.79 in 1997, and 1.32 in 2017. Table 3, column 5
shows the age-specific contributions to the changes in
gaps in life expectancy at 60 years between the two
countries during 1997 and 2017, where negative figures
indicate falls in gaps in old-age life expectancy. The age-
specific contributions to the decreased gaps were found
across all age groups, except for a small increase in the
90–94 age group, and the decreased gaps were especially
large in the 70–79 years age group. Table 4, column 5
shows the cause-specific contributions to the decreased
gap in life expectancy at 60 years in the two countries
over the time period of 1997–2017, where positive signs
indicate rises in gaps in old age life expectancy. Among
20 causes, cardiovascular disease (stroke, ischaemic heart
disease and hypertensive-heart disease) and cancer
deaths (stomach, liver, lung, pancreatic cancers), which
were leading causes of the decline in ASMRs in South
Korea between 1997 and 2017, contributed to the de-
creased gap in old-age life expectancy by 1.34 and 0.41,
respectively. On the other hand, the three causes that
showed increased ASMRs in South Korea between 1997
and 2017, lower respiratory tract disease, self-harm and
falls, contributed to increased gaps in old age life expect-
ancy between the two countries over the period. More-
over, changes in mortality pattern from two additional
causes, chronic kidney disease and Alzheimer/Dementia,
increased the gaps between the two countries over the
period. However, the increased figure in chronic kidney
disease (0.02 years) does not mean an increase in the
gap, as the gap between these countries became almost
zero in 2017, from a negative figure in 1997. In contrast,
Alzheimer’s disease and dementia, which was the highest
ASMRs for both countries in 2017, posed negative im-
pacts on the gap between the two countries by 0.09 years
during 1997–2017. Figure 4 depicts age- and cause-
specific contributions of the aggregate figures of 20
causes within the IHME’s Level 1 category to the gaps in
life expectancy at 60 years between the two countries
during 1997 and 2017. Among the 20 causes, decreased
gaps by non-communicable diseases were profound be-
tween 1997 and 2017 across all old age groups. However,
bars indicating injury-associated causes slightly ex-
panded from 1997 to 2017, especially in the age groups
after 75. Moreover, although the gaps in communicable
diseases decreased from − 0.13 to − 0.04, it should be
noted that ASMRs of lower respiratory tract disease at
an old age followed opposite trends in South Korea and
Japan. In other words, ASMRs of lower respiratory tract
disease among South Korean old adults is likely to out-
strip Japan in the future. Overall, the result showed that
causes from non-communicable diseases (cardiovascular
disease and cancers) greatly contributed to decreasing
the gaps in old-age life expectancy between South Korea
and Japan; however, certain causes from communicable
disease and injuries, in line with increased mortality pat-
terns in South Korea, led to increasing the gaps.
Discussion
This study explored the age- and cause-specific con-
tributions to the changes in life expectancy at 60 years
between Japan, the current life expectancy leader, and
South Korea, the potential future leader, during 1997
and 2017. The study showed that age- and cause-
specific contributions to the changes in old-age life
expectancy differed in the two high-income Asia-
pacific countries, and the result revealed that the de-
creasing gaps between the two countries were largely
Fig. 3 Age and cause specific contribution to the changes in old-age life expectancy of South Korea and Japan between 1997 and 2017
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due to the mortality reductions in non-communicable
diseases.
These findings are consistent with the epidemiological
transition theory and other studies demonstrating that
mortality in high-income countries is increasingly re-
lated to cardiovascular diseases (CVD) and cancers and,
additionally, the average age of death from these diseases
has shifted into older age with effective health preven-
tion [4, 23]. This study showed that, in terms of age-
specific contributions, the gaps in life expectancy among
the elderly in the two countries were the largest in their
70’s in 1997 but in their 80’s in 2017, partly implying
that South Korea experienced postponement of deaths
at an older age [9, 23–25]. In terms of cause-specific
contributions, both countries had the high ASMRs of
CVD (stroke, ischaemic heart disease) and cancers in
both 1997 and 2017, but these causes also explained
considerable parts of both the increase in old-age life ex-
pectancy within the two countries, and the decrease in
the gaps in old-age life expectancy between the two
countries [9, 11, 26].
This study also showed that the considerable contribu-
tions of CVD and cancers to the decreased gaps in old-
age life expectancy between the two countries were
largely related to the reduced ASMRs of CVD and can-
cers in South Korea. This result coincides with
Olshansky and Ault’s argument that death rates from
degenerative diseases such as cancer and stroke rapidly
decreased with effective and better healthcare services,
as a country advances into, what they referred to, ‘the
fourth stage of the epidemiologic transition: the age of de-
layed degenerative diseases’ [27]. Previous research also
showed that excellent health outcomes for old people in
South Korea were primarily the result of effective health
system performance through universal health coverage
[28–31]. Particularly, targeting the four major causes of
death, i.e., cancer, cerebrovascular, cardiovascular and
rare and incurable diseases, was a salient public health
intervention to reduce or delay mortality among old
adults in South Korea, with priority given to these four
major diseases through the National Health Insurance
(NHI) benefit package [22] including the National
Health Screening Programme (NHSP) and the National
Screening Programme for Transitional Ages (NSPTA)
[32, 33]. Therefore, the decreased gaps in old-age life ex-
pectancy between South Korea and Japan could be
mainly the result of decreased or delayed mortality of
Korean older adults from CVD and cancers by targeted
public health interventions in South Korea.
Although the epidemiological transition theory
provides the theoretical background for the de-
creased gaps in life expectancy among the elderly be-
tween the two countries, any explanation of
increases in the gaps between the two countries due
to self-harms and falls, lower respiratory tract dis-
ease, Alzheimer’s disease and dementia is incom-
plete. These causes may be a minor factor in the
overall life expectancy; however, they are found in
all three Level 1 classifications of cause of death
(communicable, non-communicable disease and in-
juries). Furthermore, the increased gaps in old-life
expectancy between South Korea and Japan resulted
from three patterns of ASMRs from those causes.
First, despite the similar levels of ASMRs of self-
harm and falls in the two countries in 1997, in 2017
South Korea’s ASMRs increased, whereas Japan’s
ASMRs decreased. Second, despite the overall higher
ASMR of lower respiratory tract disease in Japan be-
tween 1997 and 2017, South Korea’s ASMR of lower
respiratory tract disease increased, while Japan’s
ASMR decreased. Third, ASMRs of Alzheimer’s dis-
ease and dementia increased in both countries be-
tween 1997 and 2017, but increased faster in South
Korea. Although the main reasons behind the
Fig. 4 Age and cause specific contribution to the gaps in old-age life expectancy between South Korea and Japan in 1997 and 2017
Jung et al. BMC Public Health          (2020) 20:819 Page 9 of 12
increase in the gaps from these patterns are un-
doubtedly multifactorial, rapid population ageing in
South Korea may be the single most important
factor.
With regard to elderly mortality increases from self-
harm and falls in South Korea, this is partly attributed to
combined effects of South Korea’s rapid family structural
changes and population aging. For example, the propor-
tion of the elderly population living alone in South Korea
rose almost two-fold from 17% in 1990 to 33% in 2015
[34], whereas the corresponding figure only increased
moderately from 11% in 1990 to 18% in 2015 in Japan
[35]. Previous studies showed that the elderly living
alone experienced more suicidal ideation and had a
higher risk of falls than those who live with their spouse
[36–38], suggesting that the faster increase in the num-
ber of older adults living alone in South Korea resulted
in a higher risk of self-harms and falls. In addition to the
slower increase in older adults living alone in Japan,
ASMRs of self-harms and falls in Japan may have de-
clined due to the beneficial impact of a range of
community-based interventions such as depression
screening, psychiatrist follow-up of old adults and fall
prevention programmes [39–43].
With regard to lower respiratory tract disease, the
results showed that ASMRs of lower respiratory tract
disease were higher in Japan than South Korea in
both years, but the two countries had opposite
trends. It is well documented that lower respiratory
tract disease and pneumonia in high-income coun-
tries are more associated with old people and, in-
creasingly, with the Nursing Home and Healthcare
Associated Pneumonia (NHCAP) due to population
ageing, in contrast to a large prevalence of Commu-
nity Associated Pneumonia (CAP) among the youn-
ger population in low-income countries [44, 45]. In
Japan, the overall higher ASMR of lower respiratory
tract disease could be largely attributed to NHCAP,
since pneumonia is the third leading cause of mor-
tality in Japan, with 97% of these deaths occurring in
elderly patients over 65 years old [46]. Thus, the
Japan Respiratory Society (JRS) in 2011 documented
a new category of guidelines for NHCAP in order to
manage the treatment of NHCAP, particularly
among elderly residents in a long-term care hospital
or a nursing home [47]. In South Korea, following
the population ageing and the introduction of Long-
Term Care Insurance, there has been a considerable
increase in the number of Long-Term Care (LTC)
facilities, from 1,754 in 2008 to 5,242 in 2017 [48];
however, this increase in LTC providers has been ac-
companied by service quality issues in South Korea
[49]. Consequently, pneumonia is now the leading
cause of death among residents of long-term care
facilities, and unfavorable institutional factors in
long-term care facilities have often been reported as
increasing prognostic factors for pneumonia [50–52].
With regard to Alzheimer’s disease and dementia, the
observed increase in the pattern between 1997 and 2017
in both countries should be interpreted carefully, in par-
ticular due to the difficulties in reporting dementia and
Alzheimer’s disease [53]. First, there might have been
underreporting of dementia and Alzheimer’s disease as
the cause of death in 1997 due to a lack of diagnostic
tools and awareness of people in South Korea and Japan
in 1997. Second, the larger number of deaths caused by
Alzheimer’s disease and dementia in 2017 might have
been partially due to more accurate death reporting and
registration because of improved diagnostic tools and
aweareness. This study does not attempt to discuss
reporting accuracy; nonetheless, it is plausible to think
that the combination of faster population ageing and in-
creased awareness of the disease in South Korea may
have led to more cases of Alzheimer’s disease and de-
mentia in South Korea. Indeed, both countries proposed
a series of plans to promote the community-based inte-
grated care system for the elderly with dementia such as
the New Orange Plan (2015) in Japan and the third Na-
tional Dementia Management Master Plan 2016–2020
(2015) in South Korea. However, much faster population
ageing and growing awareness of Alzheimer’s disease
and dementia in South Korea may increase public health
and social burdens in the country for the next coming
years.
The first limitation of this study is that it only focused
on the top 20 causes of death based on South Korea in
2017, and thus the emerging causes of death among the
elderly in both countries may have been missed. Sec-
ondly, although life expectancy is a valid indicator of a
population’s health status, this study cannot tell whether
old adults in both countries lived longer and healthier
lives or simply experienced extended periods of morbid-
ity. Further studies to explore healthy life expectancy are
required. Lastly, this case study investigated only two
ageing countries in the Asia-pacific region. More com-
parative studies of increasing or decreasing gaps in life
expectancy between other high or middle-income Asia-
pacific countries confronting a possible double burden
of the increasing threat of non-communicable disease in
parallel with emerging communicable disease due to
demographic ageing should be carried out. Many coun-
tries in the Asian Pacific region are also experiencing ac-
celerated population ageing, and therefore their
governments are trying to prepare for sustainable
health-care systems in response to the inevitable ageing
of the population. This comparative study between high-
income Asia-pacific countries in terms of cause-specific
mortality and life expectancy can provide insights into
Jung et al. BMC Public Health          (2020) 20:819 Page 10 of 12
how to relieve the future health burden associated with
population ageing in countries in the Asian Pacific
region.
Taken together, old-age life expectancy can reflect
health and wellbeing of an elderly population and inves-
tigating gaps in old-age life expectancy between coun-
tries can facilitate cross-national policy learning in an
era of demographic ageing. This comparative study
showed that age- and cause-specific contributions to the
changes in old-age life expectancy can differ between
two high-income and ageing countries. Moreover, al-
though mortality changes in non-communicable diseases
was a key influencing factor of decreasing gaps in old-
age life expectancy between the two countries, the de-
creasing gaps might also be disturbed by emerging
threats of communicable disease and injuries along with
rapid demographic ageing.
Conclusions
This study affirms that age- and cause-specific contribu-
tions to the changes in old-age life expectancy can differ
between high-income Asia-pacific countries. Although
the gaps in old-age life expectancy between high-income
Asia-pacific countries are primarily attributed to mortal-
ity changes in non-communicable diseases, these coun-
tries should also identify potential emerging threats of
communicable diseases and injuries along with demo-
graphic ageing in pursuit of healthy life years in old age.
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